176 related articles for article (PubMed ID: 9803005)
1. Numeric alterations in chromosomes 7 and 8 detected by fluorescent in situ hybridization correlate with high-grade localized prostate cancer.
Barranco MA; Alcaraz A; Corral JM; Solé M; Mallofré C; Llopis J; Rodríguez A; Ribal MJ; Alvarez-Vijande R; Carretero P
Eur Urol; 1998; 34(5):419-25. PubMed ID: 9803005
[TBL] [Abstract][Full Text] [Related]
2. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
Takahashi S; Alcaraz A; Brown JA; Borell TJ; Herath JF; Bergstralh EJ; Lieber MM; Jenkins RB
Clin Cancer Res; 1996 Jan; 2(1):137-45. PubMed ID: 9816100
[TBL] [Abstract][Full Text] [Related]
3. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.
Brown JA; Alcaraz A; Takahashi S; Persons DL; Lieber MM; Jenkins RB
J Urol; 1994 Oct; 152(4):1157-62. PubMed ID: 8072085
[TBL] [Abstract][Full Text] [Related]
5. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
Takahashi S; Qian J; Brown JA; Alcaraz A; Bostwick DG; Lieber MM; Jenkins RB
Cancer Res; 1994 Jul; 54(13):3574-9. PubMed ID: 8012984
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal and DNA ploidy characterization of salivary gland neoplasms by combined FISH and flow cytometry.
El-Naggar AK; Dinh M; Tucker SL; Gillenwater A; Luna MA; Batsakis JG
Hum Pathol; 1997 Aug; 28(8):881-6. PubMed ID: 9269822
[TBL] [Abstract][Full Text] [Related]
7. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH.
Sauter G; Gasser TC; Moch H; Richter J; Jiang F; Albrecht R; Novotny H; Wagner U; Bubendorf L; Mihatsch MJ
Urol Res; 1997; 25 Suppl 1():S37-43. PubMed ID: 9079755
[TBL] [Abstract][Full Text] [Related]
8. Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma.
Persons DL; Gibney DJ; Katzmann JA; Lieber MM; Farrow GM; Jenkins RB
J Urol; 1993 Jul; 150(1):120-5. PubMed ID: 8510232
[TBL] [Abstract][Full Text] [Related]
9. Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH.
Farabegoli F; Santini D; Ceccarelli C; Taffurelli M; Marrano D; Baldini N
Cytometry; 2001 Feb; 46(1):50-6. PubMed ID: 11241507
[TBL] [Abstract][Full Text] [Related]
10. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.
Alcaraz A; Takahashi S; Brown JA; Herath JF; Bergstralh EJ; Larson-Keller JJ; Lieber MM; Jenkins RB
Cancer Res; 1994 Aug; 54(15):3998-4002. PubMed ID: 7518348
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorescence in situ hybridization and flow cytometric DNA ploidy analysis in paraffin-embedded prostatic adenocarcinoma specimens.
Lifson B; Pizzolo JG; Elhosseiny AA; Choudhury MS; Melamed MR
Anal Quant Cytol Histol; 1995 Apr; 17(2):93-9. PubMed ID: 7542002
[TBL] [Abstract][Full Text] [Related]
12. Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers.
König JJ; Teubel W; Romijn JC; Schröder FH; Hagemeijer A
Hum Pathol; 1996 Jul; 27(7):720-7. PubMed ID: 8698318
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy.
Brown JA; Slezak JM; Lieber MM; Jenkins RB
Mayo Clin Proc; 1999 Dec; 74(12):1214-20. PubMed ID: 10593349
[TBL] [Abstract][Full Text] [Related]
14. Tissue culture loss of aneuploid cells from carcinomas of the prostate.
König JJ; Teubel W; van Dongen JW; Hagemeijer A; Romijn JC; Schröder FH
Genes Chromosomes Cancer; 1993 Sep; 8(1):22-7. PubMed ID: 7691155
[TBL] [Abstract][Full Text] [Related]
15. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy in prostate cancer: potential measurement as a surrogate endpoint biomarker.
Lieber MM
J Cell Biochem Suppl; 1994; 19():246-8. PubMed ID: 7529855
[TBL] [Abstract][Full Text] [Related]
17. Numerical aberrations of chromosomes 8, 9, 11, and 17 in squamous cell carcinoma of the pharynx and larynx: a fluorescence in situ hybridization and DNA flow cytometric analysis of 50 cases.
Hardisson D; Alvarez-Marcos C; Salas-Bustamante A; Alonso-Guervós M; Sastre N; Sampedro A
Oral Oncol; 2004 Apr; 40(4):409-17. PubMed ID: 14969820
[TBL] [Abstract][Full Text] [Related]
18. Alteration of numerical chromosomal aberrations during progression of colorectal tumors revealed by a combined fluorescence in situ hybridization and DNA ploidy analysis of intratumoral heterogeneity.
Katsura K; Sugihara H; Nakai S; Fujita S
Cancer Genet Cytogenet; 1996 Sep; 90(2):146-53. PubMed ID: 8830725
[TBL] [Abstract][Full Text] [Related]
19. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
[TBL] [Abstract][Full Text] [Related]
20. [Combined fluorescence in situ hybridization and cytofluorometric analysis of numerical chromosomal aberrations in squamous cell carcinomas of the tongue].
Nakai S
Nihon Jibiinkoka Gakkai Kaiho; 1996 Jul; 99(7):1026-35. PubMed ID: 8776977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
